BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+9.55%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$429M
AUM Growth
+$429M
(+3.2%)
Cap. Flow
-$19M
Cap. Flow
% of AUM
-4.42%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| 1 |
STAAR Surgical
STAA
|
$7.86M |
| 2 |
Lineage Cell Therapeutics
LCTX
|
$1.08M |
Top Sells
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$27.2M |
| 2 |
Monster Beverage
MNST
|
$678K |
Sector Composition
| 1 | Healthcare | 33.78% |
| 2 | Consumer Staples | 25.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QCOR
1
DELISTED
QUESTCOR PHARMA INC
QCOR
| $152M | 30.62% |
2,796,660
-500,000
| -15% | -$27.2M |
|
|
2
STAAR Surgical
STAA
$1.37B
| $112M | 22.42% |
6,887,095
+485,456
| +8% | +$7.86M |
|
|
3
Monster Beverage
MNST
$61B
| $108M | 21.79% |
1,599,136
-10,000
| -0.6% | -$678K |
|
|
4
Lineage Cell Therapeutics
LCTX
$265M
| $33.6M | 6.75% |
9,322,262
+300,042
| +3% | +$1.08M |
|
|
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
| $21.8M | 4.38% |
817,029
| – | – |
|
|
SLTM
6
DELISTED
SOLTA MED INC (DE)
SLTM
| $2.01M | 0.4% |
680,723
| – | – |
|